Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity
Human Neks are a conserved protein kinase family related to cell cycle progression and cell division and are considered potential drug targets for the treatment of cancer and other pathologies. We screened the activation loop mutant kinases hNek1 and hNek2, wild-type hNek7, and five hNek6 variants i...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/20/1/1176 |
id |
doaj-f75be328f286473a98fb620b809f04e0 |
---|---|
record_format |
Article |
spelling |
doaj-f75be328f286473a98fb620b809f04e02020-11-24T21:27:24ZengMDPI AGMolecules1420-30492015-01-012011176119110.3390/molecules20011176molecules20011176Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor SpecificityEduardo Cruz Moraes0Gabriela Vaz Meirelles1Rodrigo Vargas Honorato2Tatiana de Arruda Campos Brasil de Souza3Edmarcia Elisa de Souza4Mario Tyago Murakami5Paulo Sergio Lopes de Oliveira6Jörg Kobarg7LaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilLaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilLaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilInstituto Carlos Chagas, FIOCRUZ, Curitiba, 81350-010 PR, BrazilLaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilLaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilLaboratórioNacional de Biociências, Centro Nacional de PesquisaemEnergia e Materiais, Campinas, 13083-970 SP, BrazilPrograma de Pós-graduação em Biologia Funcional e Molecular, Departamento de Bioquímica e BiologiaTecidual, Instituto de Biologia, UniversidadeEstadual de Campinas, Campinas, 13083-862 SP, BrazilHuman Neks are a conserved protein kinase family related to cell cycle progression and cell division and are considered potential drug targets for the treatment of cancer and other pathologies. We screened the activation loop mutant kinases hNek1 and hNek2, wild-type hNek7, and five hNek6 variants in different activation/phosphorylation statesand compared them against 85 compounds using thermal shift denaturation. We identified three compounds with significant Tm shifts: JNK Inhibitor II for hNek1(Δ262-1258)-(T162A), Isogranulatimide for hNek6(S206A), andGSK-3 Inhibitor XIII for hNek7wt. Each one of these compounds was also validated by reducing the kinases activity by at least 25%. The binding sites for these compounds were identified by in silico docking at the ATP-binding site of the respective hNeks. Potential inhibitors were first screened by thermal shift assays, had their efficiency tested by a kinase assay, and were finally analyzed by molecular docking. Our findings corroborate the idea of ATP-competitive inhibition for hNek1 and hNek6 and suggest a novel non-competitive inhibition for hNek7 in regard to GSK-3 Inhibitor XIII. Our results demonstrate that our approach is useful for finding promising general and specific hNekscandidate inhibitors, which may also function as scaffolds to design more potent and selective inhibitors.http://www.mdpi.com/1420-3049/20/1/1176drug discoverycompound screeningkinase assaysmolecular modelingmolecular dockingATP-competitive inhibitorsnon-competitive inhibitionNeks |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eduardo Cruz Moraes Gabriela Vaz Meirelles Rodrigo Vargas Honorato Tatiana de Arruda Campos Brasil de Souza Edmarcia Elisa de Souza Mario Tyago Murakami Paulo Sergio Lopes de Oliveira Jörg Kobarg |
spellingShingle |
Eduardo Cruz Moraes Gabriela Vaz Meirelles Rodrigo Vargas Honorato Tatiana de Arruda Campos Brasil de Souza Edmarcia Elisa de Souza Mario Tyago Murakami Paulo Sergio Lopes de Oliveira Jörg Kobarg Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity Molecules drug discovery compound screening kinase assays molecular modeling molecular docking ATP-competitive inhibitors non-competitive inhibition Neks |
author_facet |
Eduardo Cruz Moraes Gabriela Vaz Meirelles Rodrigo Vargas Honorato Tatiana de Arruda Campos Brasil de Souza Edmarcia Elisa de Souza Mario Tyago Murakami Paulo Sergio Lopes de Oliveira Jörg Kobarg |
author_sort |
Eduardo Cruz Moraes |
title |
Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity |
title_short |
Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity |
title_full |
Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity |
title_fullStr |
Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity |
title_full_unstemmed |
Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity |
title_sort |
kinase inhibitor profile for human nek1, nek6, and nek7 and analysis of the structural basis for inhibitor specificity |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2015-01-01 |
description |
Human Neks are a conserved protein kinase family related to cell cycle progression and cell division and are considered potential drug targets for the treatment of cancer and other pathologies. We screened the activation loop mutant kinases hNek1 and hNek2, wild-type hNek7, and five hNek6 variants in different activation/phosphorylation statesand compared them against 85 compounds using thermal shift denaturation. We identified three compounds with significant Tm shifts: JNK Inhibitor II for hNek1(Δ262-1258)-(T162A), Isogranulatimide for hNek6(S206A), andGSK-3 Inhibitor XIII for hNek7wt. Each one of these compounds was also validated by reducing the kinases activity by at least 25%. The binding sites for these compounds were identified by in silico docking at the ATP-binding site of the respective hNeks. Potential inhibitors were first screened by thermal shift assays, had their efficiency tested by a kinase assay, and were finally analyzed by molecular docking. Our findings corroborate the idea of ATP-competitive inhibition for hNek1 and hNek6 and suggest a novel non-competitive inhibition for hNek7 in regard to GSK-3 Inhibitor XIII. Our results demonstrate that our approach is useful for finding promising general and specific hNekscandidate inhibitors, which may also function as scaffolds to design more potent and selective inhibitors. |
topic |
drug discovery compound screening kinase assays molecular modeling molecular docking ATP-competitive inhibitors non-competitive inhibition Neks |
url |
http://www.mdpi.com/1420-3049/20/1/1176 |
work_keys_str_mv |
AT eduardocruzmoraes kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT gabrielavazmeirelles kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT rodrigovargashonorato kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT tatianadearrudacamposbrasildesouza kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT edmarciaelisadesouza kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT mariotyagomurakami kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT paulosergiolopesdeoliveira kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity AT jorgkobarg kinaseinhibitorprofileforhumannek1nek6andnek7andanalysisofthestructuralbasisforinhibitorspecificity |
_version_ |
1725974833936728064 |